WebJun 14, 2012 · BioNumerik Pharmaceuticals, Inc., based in San Antonio, Texas, is focused on the discovery, development and commercialization of novel drugs for the treatment of cancer and cancer supportive care ... WebRyan Dokich was associated with Bionumerik Pharmaceuticals, Inc. between 2012 and 2014. They may have been associated with this organization before or after these years as well. Bionumerik Pharmaceuticals, Inc. Business Data 8122 Datapoint Dr # 1250, San Antonio, TX 78229, USA, Texas
James R. Leininger - James R. Leininger - abcdef.wiki
WebThis patent search tool allows you not only to search the PCT database of about 2 million International Applications but also the worldwide patent collections. This search facility features: flexible search syntax; automatic word stemming and relevance ranking; as well as graphical results. WebPrior to joining BioNumerik Pharmaceuticals, Inc., Mr. Margrave was a partner at Andrews & Kurth LLP, a national law firm. Mr. Margrave serves as Chairman and a board member of the Texas Healthcare and Bioscience … dallas cowboys former tight ends
BioNumerik Pharmaceuticals - Crunchbase Company …
WebJan 21, 2010 · SAN ANTONIO, Jan. 21 /PRNewswire/ -- BioNumerik Pharmaceuticals, Inc. ("BioNumerik") today announced the treatment of the first patients in a global multi-center Phase III clinical trial of Tavocept (BNP7787) in patients with primary adenocarcinoma of the lung, the most common type of lung cancer. WebThe estimated total pay for a BioNumerik Pharmaceuticals is $55,502 per year in the United States area, with an average salary of $51,532 per year. These numbers represent the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. The estimated additional pay is ... WebJul 17, 2008 · SAN ANTONIO, July 17 /PRNewswire/ -- BioNumerik Pharmaceuticals, Inc. ("BioNumerik") today announced that patients with adenocarcinoma (the most frequently occurring form of lung cancer) participating in a Phase II clinical trial of Tavocept(TM) showed a survival increase of approximately 198 days (6.5 months). The trial … dallas cowboys former coaches